News

InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved ...
For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide ...
New findings reveal mirvetuximab soravtansine significantly improves outcomes in patients with recurrent platinum-sensitive ...
This valuable manuscript investigates the localisation of nutrient receptors in bloodstream stage trypanosomes, with implications for both nutrient uptake and immune evasion. Results after direct ...
For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide ...
India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's Mounjaro, which gained early traction. Both drugs address rising obesity and ...
Onco360 ®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA ™ (vimseltinib), which has been ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
Find lists of blood pressure medications commonly used to treat hypertension and the names of medications prescribed less often.
Hyperspectral imaging has provided an insight into how cells organize and prioritize organelle growth.